Key indicators: single-crystal X-ray study; T = 113 K; mean (C-C) = 0.003 Å; R factor = 0.031; wR factor = 0.090; data-to-parameter ratio = 13.0.
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Crystal data 
Comment
Fused pyrimidine derivatives represent important target molecules due to their highly pronounced biological properties. (Ashok et al., 2007; Monks et al., 1991) . In this paper, the structure of the title compound (I) is reported (Fig. 1) .
The thiazole ring (C5-N1-C15-C16-S1) has the usual essentially planar geometry observed in other fused thiazolopyrimidine compounds (Liu et al., 2004; Sridhar et al., 2006; Hou, 2009 ). The thiazole ring makes a dihedral angles of 90.3 (2) ° with the benzene ring (C9-C14). The pyrimidine ring adopts a flattened half-chair conformation. The C16-C17 double bond exist in the Z configuration. Molecular packing (Fig. 2) is stabilized mainly by weak van der Waals forces.
Experimental
A mixture of ethyl 2-mercapto-4-methyl-6-(4-chlorophenyl)-1,6-dihydro-pyrimidine-5-carboxylate (0.01 mol), dimethyl acetylenedicarboxylate (0.01 mol) in methanol (25 ml) was refluxed for 3 h. The reaction mixture was cooled and filtered.
The resulting solid was collected and crystallized from methanol to obtain the final product (90% yield, mp 434-435 K). Figures Fig. 1 . The molecular structure of (I), drawn with 30% probability ellipsoids. H atoms have been omitted for clarity. 0.0144 (7) 0.0281 (7) 0.0257 (7) 0.0108 (6) 0.0070 (5) 0.0152 (6) O4 0.0203 (7) 0.0257 (7) 0.0259 (7) 0.0094 (6) 0.0118 (6) 0.0108 (6) O5 0.0321 (8) 0.0242 (7) 0.0363 (7) 0.0160 (7) 0.0232 (7) 0.0200 (6 
